Malta - inglês - Medicines Authority

baxter healthcare limited - calcium chloride dihydrate; phenylalanine; histidine; arginine; alanine; threonine; tryptophan; tyrosine; valine; glycine; methionine; isoleucine; lysine; magnesium chloride hexahydrate; serine; leucine; proline; sodium chloride; sodium lactate - solution for peritoneal dialysis - calcium chloride dihydrate 184 mg/l; phenylalanine 570 mg/l; histidine 714 mg/l; arginine 1071 mg/l; alanine 951 mg/l; threonine 646 mg/l; tryptophan 270 mg/l; tyrosine 300 mg/l; valine 1393 mg/l; glycine 510 mg/l; methionine 850 mg/l; isoleucine 850 mg/l; lysine 955 mg/l; magnesium chloride hexahydrate 51 mg/l; serine 510 mg/l; leucine 1020 mg/l; proline 595 mg/l; sodium chloride 5380 mg/l; sodium lactate 4480 mg/l - blood substitutes and perfusion solutions

Malta - inglês - Medicines Authority

baxter healthcare limited caxton way, thetford, norfolk ip24 3se, united kingdom - calcium chloride, dihydrate, phenylalanine, histidine, arginine, threonine, tryptophan, tyrosine, valine, glycine, methionine, isoleucine, lysine, magnesium chloride, hexahydrate, serine, proline, sodium chloride, sodium lactate - solution for peritoneal dialysis - calcium chloride dihydrate 184 mg/ml phenylalanine 570 mg/ml histidine 714 mg/ml arginine 1071 mg/ml alanine 951 mg/ml threonine 646 mg/ml tryptophan 270 mg/ml tyrosine 300 mg/ml valine 1393 mg/ml glycine 510 mg/ml methionine 850 mg/ml isoleucine 850 mg/ml lysine 955 mg/ml magnesium chloride hexahydrate 51 mg/ml serine 510 mg/ml leucine 1020 mg/ml proline 595 mg/ml sodium chloride 5380 mg/ml sodium lactate 4480 mg/ml - blood substitutes and perfusion solutions

Malta - inglês - Medicines Authority

baxter healthcare limited - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - emulsion for infusion - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - blood substitutes and perfusion solutions

Malta - inglês - Medicines Authority

baxter healthcare limited - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - emulsion for infusion - phenylalanine; histidine; arginine; aspartic acid; olive oil; alanine; threonine; tyrosine; valine; glucose monohydrate 250 g; glutamic acid; glycine; methionine; isoleucine; l-tryptophan; lysine; serine; leucine; proline; soybean oil - blood substitutes and perfusion solutions

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

jeunesse global australia pty ltd - isoleucine, quantity: 163.4 mg/g; phenylalanine, quantity: 46.67 mg/g; leucine, quantity: 163.4 mg/g; methionine, quantity: 26.67 mg/g; cystine, quantity: 16.67 mg/g; threonine, quantity: 40 mg/g; lysine, quantity: 66.67 mg/g; valine, quantity: 163.4 mg/g; tyrosine, quantity: 20 mg/g - powder, oral - excipient ingredients: acacia; malic acid; sucralose; glycine; colloidal anhydrous silica; flavour - maintain/support collagen formation ; maintain/support energy production ; maintain/support general health and wellbeing ; aid/assist muscle growth ; maintain/support muscle protein stores ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

jeunesse global australia pty ltd - leucine, quantity: 163.4 mg/g; methionine, quantity: 26.67 mg/g; phenylalanine, quantity: 46.67 mg/g; cystine, quantity: 16.67 mg/g; lysine, quantity: 66.67 mg/g; isoleucine, quantity: 163.4 mg/g; tyrosine, quantity: 20 mg/g; valine, quantity: 163.4 mg/g; threonine, quantity: 40 mg/g - powder, oral - excipient ingredients: glycine; colloidal anhydrous silica; acacia; malic acid; sucralose; flavour - maintain/support collagen formation ; maintain/support energy production ; maintain/support general health and wellbeing ; aid/assist muscle growth ; maintain/support muscle protein stores ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

pharmametics products a division of max biocare pty ltd - vitex agnus-castus, quantity: 10 mg (equivalent: vitex agnus-castus, qty 100 mg); tyrosine, quantity: 250 mg; folic acid, quantity: 90 microgram; calcium hydrogen phosphate dihydrate, quantity: 450 mg (equivalent: calcium, qty 103.5 mg); cyanocobalamin, quantity: 5 microgram; epimedium sagittatum, quantity: 50 mg (equivalent: epimedium sagittatum, qty 1 g); panax ginseng, quantity: 50 mg (equivalent: panax ginseng, qty 500 mg) - tablet, film coated - excipient ingredients: magnesium stearate; carnauba wax; macrogol 400; hypromellose; maltodextrin; povidone; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; iron oxide red; titanium dioxide - relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support general health and wellbeing ; maintain/support healthy blood circulation ; maintain/support blood health ; maintain/support cardiovascular system health ; helps maintain/support vasodilator/ blood vessel dilation ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; support healthy emotional/mood balance ; maintain/support female healthy hormonal balance ; maintain/support healthy female hormonal balance during menopause ; aphrodisiac/enhance/improve/promote healthy libido ; maintain/support healthy sexual function

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

blueskygreenearth herbs pty ltd - citrus aurantium, quantity: 57.15 mg (equivalent: citrus aurantium, qty 342.9 mg; equivalent: oxedrine, qty 6.8 mg); boswellia serrata, quantity: 57.15 mg (equivalent: boswellia serrata, qty 342.9 mg); plectranthus barbatus, quantity: 71.4 mg (equivalent: plectranthus barbatus, qty 428.4 mg); tyrosine, quantity: 100 mg; garcinia quaesita, quantity: 714.3 mg (equivalent: garcinia quaesita, qty 4.29 g; equivalent: hydroxycitric acid, qty 85 mg) - tablet, uncoated - excipient ingredients: maize starch; microcrystalline cellulose; magnesium stearate; dextrin - traditionally used in ayurvedic medicine to decrease/reduce/relieve mild rheumatic aches and pains

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - ponatinib hydrochloride, quantity: 48.1 mg (equivalent: ponatinib, qty 45 mg) - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; lactose monohydrate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - iclusig is indicated for the treatment of adult patients with:,chronic phase (cp), accelerated phase (ap), or blast phase (bp) chronic myeloid ieukaemia (cml) whose disease is resistant to, or who are intolerant of at least two prior tyrosine kinase inhibitors; or where there is a t315i mutation.,philadelphia chromosome positive acute lymphoblastic ieukaemia (ph+ all) whose disease is resistant to, or who are intolerant of dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or where there is a t315i mutation.,therapy with iclusig should be initiated and monitored by a haematologist with expertise in managing adult ieukaemias.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - ponatinib hydrochloride, quantity: 16 mg (equivalent: ponatinib, qty 15 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - iclusig is indicated for the treatment of adult patients with:,chronic phase (cp), accelerated phase (ap), or blast phase (bp) chronic myeloid ieukaemia (cml) whose disease is resistant to, or who are intolerant of at least two prior tyrosine kinase inhibitors; or where there is a t315i mutation.,philadelphia chromosome positive acute lymphoblastic ieukaemia (ph+ all) whose disease is resistant to, or who are intolerant of dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or where there is a t315i mutation.,therapy with iclusig should be initiated and monitored by a haematologist with expertise in managing adult ieukaemias.